By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CytoSorbents, Inc. 

7 Deer Park Drive
Suite K
Monmouth Junction  New Jersey  08852  U.S.A.
Phone: 732-329-8885 Fax: 732-329-8650


SEARCH JOBS

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb is CE Mark certified and is currently distributed in 37 countries around the world as a safe and effective extracorporeal cytokine adsorber, designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis, as well as in cancer immunotherapy.

YEAR FOUNDED:

February 2012

LEADERSHIP:

Founders: Christian Steiner and Phillip Chan

CEO: Phillip Chan

JOBS:

Please click here for CytoSorbents job opportunities.

FOLLOW CYTOSORBENTS:



Key Statistics


Email: info@cytosorbents.com
Ownership: Private

Web Site: CytoSorbents
Employees:
Symbol: 
 



Industry
Medical Device






Company News
CytoSorbents Launches VetResQ For U.S. Veterinary Market 1/20/2017 8:05:49 AM
CytoSorbents Release: Medical Device Company Pre-Announces Q4 2016 And Full-Year 2016 Results 1/10/2017 2:24:01 PM
Fresenius Medical Care (FMS) And CytoSorbents Expand Original Partnership And Add New Co-Marketing Agreement For Worldwide CytoSorb Markets 1/9/2017 7:22:53 AM
CytoSorbents Announces First Sales Of New CytoSorb CPB Procedure Pack For Cardiac Surgery 12/20/2016 11:52:21 AM
CytoSorbents Receives $318,551 In Non-Dilutive Funding From The New Jersey Technology Business Tax Certificate Transfer Program 12/12/2016 7:52:00 AM
CytoSorbents Release: CytoSorb Attains Permanent, Dedicated Reimbursement Code In Core Market Of Germany 12/7/2016 8:52:10 AM
CytoSorbents Release: CytoSorb Selected For NICE MedTech Innovation Briefing In The United Kingdom 12/1/2016 12:29:43 PM
CytoSorbents Release: First Successful Treatment Of Dengue Fever And Dengue Shock Syndrome Using CytoSorb 11/22/2016 7:38:12 AM
CytoSorbents Release: CytoSorb Q3 2016 Sales Reach Record $2.14M, Doubling From A Year Ago 11/9/2016 11:07:09 AM
CytoSorbents Expands Direct Sales Of CytoSorb To Belgium And Luxembourg 11/3/2016 8:39:31 AM
12345678910...
//-->